Resistin: A pathogenic factor or a biomarker of metabolic disorders and infl ammation?
Cardiovascular diseases are currently the most frequent cause of death in Poland and their incidence continually rises. This is related to the high incidence of obesity associated with insulin resistance, which is present in type 2 diabetes mellitus. Adipose tissue produces multiple cytokines (TNF-a...
Main Authors: | Aleksandra Karbowska, Maria Boratyńska, Marian Klinger |
---|---|
Format: | Article |
Language: | English |
Published: |
Index Copernicus International S.A.
2009-10-01
|
Series: | Postępy Higieny i Medycyny Doświadczalnej |
Subjects: | |
Online Access: | http://journals.indexcopernicus.com/fulltxt.php?ICID=896900 |
Similar Items
-
Modulation of infl ammation in Alzheimer’s disease and omega-3 fatty acids
by: Katarzyna Szczechowiak, et al.
Published: (2019-05-01) -
Resistin, inflammation and dyslipidemia in obese children and adolescents
by: Pavlović Branko, et al.
Published: (2015-01-01) -
Role of Resveratrol on the Effect of Resistin in Rabbit Corpus Cavernosum
by: Türkan Güngör, et al.
Published: (2020-09-01) -
The role of resistin in the genesis of metabolic disorders in pathological pregnancy
by: S. O. Ostafiichuk
Published: (2019-10-01) -
Associations of resistin levels with resistin gene polymorphism and Metabolic syndrome in Thais
by: Suriyaprom Kanjana, et al.
Published: (2015-01-01)